Although first-line drugs targeting glucose/lipid metabolism such as metformin, thiazolidinediones, and sodium-glucose cotransporter-2 inhibitors alleviate hyperglycemia, their exact effects on DCM need further exploration in diabetic animal models and patients. The gene discussed is SLC5A2; the disease is Hyperglycemia.